{"id":"https://openalex.org/W2068354564","doi":"https://doi.org/10.1046/j.1523-5394.1998.006003195.x","title":"Rituximab: A New Therapeutic Monoclonal Antibody for Non\u2010Hodgkin's Lymphoma","display_name":"Rituximab: A New Therapeutic Monoclonal Antibody for Non\u2010Hodgkin's Lymphoma","alternate_titles":[],"publication_year":1998,"publication_date":"1998-05-01","ids":{"openalex":"https://openalex.org/W2068354564","doi":"https://doi.org/10.1046/j.1523-5394.1998.006003195.x","mag":"2068354564","pmid":"https://pubmed.ncbi.nlm.nih.gov/9652253"},"language":"en","primary_location":{"id":"doi:10.1046/j.1523-5394.1998.006003195.x","doi":"https://doi.org/10.1046/j.1523-5394.1998.006003195.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1523-5394.1998.006003195.x","pdf_url":null,"source":{"id":"https://openalex.org/S67363003","display_name":"Cancer Practice","issn_l":"1065-4704","issn":["1065-4704","1523-5394"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Practice","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2068354564"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Shane D. Scott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126307644","display_name":"University of Iowa","ror":"https://ror.org/036jqmy94","country_code":"US","type":"education","lineage":["https://openalex.org/I126307644"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Shane D. Scott","raw_affiliation_strings":["University of Iowa College of Pharmacy, Division of Clinical and Administrative Pharmacy, Iowa City, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Iowa College of Pharmacy, Division of Clinical and Administrative Pharmacy, Iowa City, USA","institution_ids":["https://openalex.org/I126307644"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I126307644"],"apc_list":null,"apc_paid":null,"fwci":0.5126,"has_fulltext":false,"cited_by_count":122,"citation_normalized_percentile":{"value":0.6592579,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":99},"biblio":{"volume":"6","issue":"3","first_page":"195","last_page":"197"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":1.0},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.9700000286102295},{"id":"https://openalex.org/keywords/indolent-lymphoma","display_name":"indolent lymphoma","score":0.7720000147819519},{"id":"https://openalex.org/keywords/follicular-lymphoma","display_name":"follicular lymphoma","score":0.9860000014305115},{"id":"https://openalex.org/keywords/monoclonal-antibody-therapy","display_name":"monoclonal antibody therapy","score":0.8939999938011169},{"id":"https://openalex.org/keywords/outpatient-care","display_name":"outpatient care","score":0.6079999804496765},{"id":"https://openalex.org/keywords/retreatment","display_name":"retreatment","score":0.8309999704360962},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7760000228881836},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.652999997138977}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9639360904693604},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.9421218633651733},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6444768309593201},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.6194977760314941},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5578756332397461},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5446226000785828},{"id":"https://openalex.org/C2778476748","wikidata":"https://www.wikidata.org/wiki/Q1138590","display_name":"Non-Hodgkin's lymphoma","level":3,"score":0.5431267023086548},{"id":"https://openalex.org/C2777058707","wikidata":"https://www.wikidata.org/wiki/Q123251","display_name":"Follicular lymphoma","level":3,"score":0.5386519432067871},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.5354611277580261},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.47538721561431885},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.46956896781921387},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.4479066729545593},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3436075448989868},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.34045737981796265}],"mesh":[{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1523-5394.1998.006003195.x","doi":"https://doi.org/10.1046/j.1523-5394.1998.006003195.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1523-5394.1998.006003195.x","pdf_url":null,"source":{"id":"https://openalex.org/S67363003","display_name":"Cancer Practice","issn_l":"1065-4704","issn":["1065-4704","1523-5394"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Practice","raw_type":"journal-article"},{"id":"pmid:9652253","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9652253","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer practice","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.979200005531311,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W57940270","https://openalex.org/W60759546","https://openalex.org/W206701898","https://openalex.org/W2032423298","https://openalex.org/W2098698745","https://openalex.org/W2104940816","https://openalex.org/W2112476236","https://openalex.org/W2127385921"],"related_works":["https://openalex.org/W1775798896","https://openalex.org/W1988520649","https://openalex.org/W2107240029","https://openalex.org/W4210380946","https://openalex.org/W1982844809","https://openalex.org/W2945813730","https://openalex.org/W2403988497","https://openalex.org/W1540507981","https://openalex.org/W1994238263","https://openalex.org/W2079365532"],"abstract_inverted_index":{"Rituximab":[0],"is":[1,36,53],"an":[2],"effective":[3,37],"single":[4],"agent":[5],"available":[6],"for":[7],"short-course":[8],"outpatient":[9],"treatment":[10,65],"in":[11,71,78],"low-grade":[12,72],"NHL,":[13],"particularly":[14],"with":[15,38,60],"follicular":[16],"histology":[17],"(IWF":[18],"B-D),":[19],"that":[20,34,57],"offers":[21],"a":[22],"relatively":[23],"nontoxic":[24],"alternative":[25],"to":[26,45,63],"chemotherapy":[27],"regimens":[28,56],"currently":[29],"available.":[30],"Early":[31],"indications":[32],"are":[33],"retreatment":[35],"similar":[39],"levels":[40],"of":[41,49,55],"predictable":[42],"adverse":[43],"events":[44],"the":[46],"initial":[47],"course":[48],"therapy.":[50],"Further":[51],"development":[52],"awaited":[54],"combine":[58],"rituximab":[59],"chemotherapeutic":[61],"agents":[62],"enhance":[64],"efficacy":[66],"without":[67],"overlapping":[68],"side":[69],"effects":[70],"NHL":[73],"as":[74,76],"well":[75],"use":[77],"other":[79],"CD20+":[80],"malignancies.":[81]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2068354564","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":14},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
